Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer

Dearnaley, 2016, Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial, Lancet Oncol, 17, 1047, 10.1016/S1470-2045(16)30102-4 Lalonde, 2014, Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study, Lancet Oncol, 15, 1521, 10.1016/S1470-2045(14)71021-6 Epstein, 2005, The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1 Epstein, 2016, The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system, Am J Surg Pathol, 40, 244, 10.1097/PAS.0000000000000530 Epstein, 2016, A contemporary prostate cancer grading system: a validated alternative to the Gleason score, Eur Urol, 69, 428, 10.1016/j.eururo.2015.06.046 Humphrey, 2016 Berney, 2016, Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome, Br J Cancer, 114, 1078, 10.1038/bjc.2016.86 McCarthy, 2011, High-density tissue microarrays from prostate needle biopsies, J Clin Pathol, 64, 88, 10.1136/jcp.2010.082339 Cancer Research UK. Testing Times to come: An evaluation of Pathology Capacity across the UK, 2016.